Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketoreductase Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106566851B reveals a KRED-catalyzed route for Chloramphenicol. High purity, reduced cost, scalable manufacturing for global supply chains.
Patent CN109797174B reveals high-yield ketoreductase route. Reduces heavy metal waste, ensures 100% ee. Ideal for veterinary API supply chains.
Patent CN102978249A details a single-enzyme biocatalytic route for statin intermediates. Achieve >99% ee with simplified workup and reduced manufacturing costs.
Patent CN105985990B details a green enzymatic route for phenylephrine intermediates using KRED and antioxidants, offering significant cost reduction in API manufacturing.
Patent CN109957585B reveals a high-efficiency ketoreductase process for chiral alcohol intermediates, offering significant cost reduction and scalable supply chain solutions.
Patent CN118516426A reveals enzymatic route for chiral intermediates. High purity, mild conditions, cost-effective for pharma supply chains.
Patent CN111575334B reveals a stable immobilized enzyme method for synthesizing chiral alcohols, offering significant cost reduction and supply reliability for API manufacturing.
Patent CN103554016B reveals enzymatic synthesis for high-purity API intermediates. Achieve substantial cost reduction and supply chain reliability with scalable green chemistry solutions.
Patent CN115976130A reveals a novel enzymatic route for Rimegepant intermediate VI, achieving 90.1% yield and superior impurity control for reliable pharmaceutical supply chains.
Patent CN103468757A details a green enzymatic reduction for Atazanavir intermediates, offering high purity and safer manufacturing for pharmaceutical supply chains.
Patent CN115820782A reveals a green enzymatic route for 7-dehydrocholesterol intermediates, offering superior purity and yield for Vitamin D3 synthesis.
Novel enzymatic synthesis route for high-purity chiral alcohol intermediate. Reduces cost and improves safety for pharmaceutical manufacturing supply chains.